Vivo Capital

Latest statistics and disclosures from Vivo Capital's latest quarterly 13F-HR filing:

Companies in the Vivo Capital portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Aclaris Therapeutics 19.52 2.86M 27.12
Biohaven Pharmaceutical Holding Company 12.45 1.98M NEW 25.00
Ascendis Pharma A S 12.35 1.77M 27.76
Nabriva Therapeutics Ag 10.61 4.02M 10.48
Codexis Inc 7.27 5.29M 5.45
Selecta Biosciences 5.60 1.12M NEW 19.86
Strongbridge Bioph shs usd 5.40 3.00M 7.15
Aimmune Therapeutics 4.02 776813 20.56
Eiger Biopharmaceuticals 3.56 1.79M 7.90
Advanced Accelerat spon ads each rep 2 ord shs 3.53 358786 -25% 39.04
Verona Pharma Plc ads 2.07 704225 NEW 11.66
Capnia 1.85 14.70M 0.50
Biopharmx 1.70 14.10M +10% 0.48
Aurinia Pharmaceuticals 1.56 1.01M +68% 6.13
Agile Therapeutics 1.43 1.51M 3.75
Trevena 1.00 1.73M 2.30
Foamix Pharmaceuticals Ltd shs 1.00 855000 4.64
Dynavax Technologies 0.87 359827 9.65
Regenxbio Inc equity us cm 0.82 164403 19.75
Pronai Therapeutics 0.72 2.44M NEW 1.17
Akari Therapeutics 0.61 527842 4.61
Crispr Therapeutics Ag 0.60 148878 16.02
Kalvista Pharmaceuticals 0.56 300325 NEW 7.36
Revance Therapeutics 0.51 77373 26.40
Sunesis Pharmaceuticals Inc Ne 0.34 500000 2.70
Capnia Inc Common Stock Warrants 0.04 943858 0.17

Past 13F-HR SEC Filings by Vivo Capital

View All Filings